display Latest news from Cardiovascular Research Foundation (CRF) on Newswise en-us Copyright 2024 Newswise 115 31 / /images/newswise-logo-rss.gif /articles/symbiosis-wins-tct-2024-shark-tank-innovation-competition/?sc=rsin /articles/symbiosis-wins-tct-2024-shark-tank-innovation-competition/?sc=rsin Wed, 06 Nov 2024 10:30:12 EST The Cardiovascular Research Foundation(r) (CRF(r)) is pleased to announce that Symbiosis has won the TCT(r) 2024 Shark Tank Innovation Competition for its development of an adjustable transcatheter mitral valve replacement (TMVR) system. The competition took place during Transcatheter Cardiovascular Therapeutics(r) (TCT(r)), the annual scientific symposium of CRF(r) and the world's premier educational meeting specializing in interventional cardiovascular medicine, October 27-30 in Washington, DC. The winner was also presented with the Jon DeHaan Foundation Award for Innovation in Cardiology. Cardiovascular Research Foundation (CRF) /articles/randomized-trial-demonstrates-benefits-of-large-bore-mechanical-thrombectomy-over-catheter-directed-thrombolysis-for-treatment-of-intermediate-risk-pulmonary-embolism/?sc=rsin /articles/randomized-trial-demonstrates-benefits-of-large-bore-mechanical-thrombectomy-over-catheter-directed-thrombolysis-for-treatment-of-intermediate-risk-pulmonary-embolism/?sc=rsin Wed, 30 Oct 2024 12:00:02 EST Findings from the first international randomized controlled trial to compare patient outcomes following treatment with large-bore mechanical thrombectomy (LBMT) versus catheter-directed thrombolysis (CDT) for intermediate-risk pulmonary embolism (PE) found that LBMT is superior with respect to the hierarchically-tested aggregated outcome of all-cause mortality, intracranial hemorrhage, major bleeding, clinical deterioration and/or escalation to bailout therapy, and postprocedural ICU admission and length of stay. Findings were reported today at TCT 2024, the annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine. Results were also published simultaneously in Circulation. Cardiovascular Research Foundation (CRF) /articles/routine-colchicine-administration-after-acute-myocardial-infarction-does-not-improve-outcomes/?sc=rsin /articles/routine-colchicine-administration-after-acute-myocardial-infarction-does-not-improve-outcomes/?sc=rsin Wed, 30 Oct 2024 11:55:05 EST The largest trial to examine the impact of colchicine in acute myocardial infarction (MI) found that both acute and long-term colchicine use did not reduce cardiovascular death, myocardial infarction, stroke, or ischemia-driven revascularization. Cardiovascular Research Foundation (CRF) /articles/orbital-atherectomy-prior-to-coronary-stent-implantation-does-not-lead-to-better-outcomes-compared-to-conventional-balloon-angioplasty/?sc=rsin /articles/orbital-atherectomy-prior-to-coronary-stent-implantation-does-not-lead-to-better-outcomes-compared-to-conventional-balloon-angioplasty/?sc=rsin Wed, 30 Oct 2024 11:05:34 EST Results from the large-scale randomized ECLIPSE trial found that a lesion preparation strategy of routine orbital atherectomy had similar outcomes compared with conventional balloon angioplasty prior to implantation of a drug-eluting stent (DES) in severely calcified coronary arteries. Cardiovascular Research Foundation (CRF) /articles/transcatheter-aortic-valve-replacement-in-patients-with-systolic-heart-failure-and-moderate-aortic-stenosis-shows-limited-benefits/?sc=rsin /articles/transcatheter-aortic-valve-replacement-in-patients-with-systolic-heart-failure-and-moderate-aortic-stenosis-shows-limited-benefits/?sc=rsin Tue, 29 Oct 2024 11:50:37 EST Findings from the TAVR UNLOAD study found limited benefits of transcatheter aortic valve replacement (TAVR) in the treatment of heart failure (HF) with reduced ejection fraction (HFrEF) and moderate aortic stenosis (AS). Findings were reported today at TCT 2024, the annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine. The results were also published simultaneously in the Journal of the American College of Cardiology. Cardiovascular Research Foundation (CRF) /articles/early-intervention-in-patients-with-asymptomatic-severe-aortic-stenosis-and-myocardial-fibrosis-falls-short-of-expected-benefits/?sc=rsin /articles/early-intervention-in-patients-with-asymptomatic-severe-aortic-stenosis-and-myocardial-fibrosis-falls-short-of-expected-benefits/?sc=rsin Tue, 29 Oct 2024 11:40:28 EST The EVOLVED trial found that early aortic valve intervention in patients with asymptomatic severe aortic stenosis (AS) and mid-wall myocardial fibrosis on magnetic resonance imaging did not reduce the incidence of the composite primary endpoint of all-cause death or unplanned aortic stenosis hospitalization compared with guideline-directed conservative management. Findings were reported today at TCT 2024, the annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine. The results were also published simultaneously in the Journal of the American Medical Association. Cardiovascular Research Foundation (CRF) /articles/study-finds-early-tavr-can-be-beneficial-for-patients-with-asymptomatic-severe-aortic-stenosis/?sc=rsin /articles/study-finds-early-tavr-can-be-beneficial-for-patients-with-asymptomatic-severe-aortic-stenosis/?sc=rsin Tue, 29 Oct 2024 11:35:18 EST The first powered randomized trial examining early intervention with transcatheter aortic valve replacement (TAVR) in patients with asymptomatic, severe aortic stenosis (AS) found this strategy to be both a safe and effective alternative to clinical surveillance (CS). Findings were reported today at TCT 2024, the annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine. Results were also published simultaneously in the New England Journal of Medicine. Cardiovascular Research Foundation (CRF) /articles/crf-announces-2024-set-10-rankings/?sc=rsin /articles/crf-announces-2024-set-10-rankings/?sc=rsin Wed, 23 Oct 2024 12:55:39 EST The Cardiovascular Research Foundation(r) (CRF(r)) is proud to unveil the 2024 SET-10 (Scientific Excellence Top 10), recognizing the academic and medical institutions making the most impactful contributions to interventional cardiovascular research at TCT(r) 2024 (Transcatheter Cardiovascular Therapeutics(r)), the annual scientific symposium of CRF(r). Cardiovascular Research Foundation (CRF) /articles/medtech-innovation-takes-center-stage-at-tct-2024/?sc=rsin /articles/medtech-innovation-takes-center-stage-at-tct-2024/?sc=rsin Fri, 11 Oct 2024 10:05:03 EST As the pace of change accelerates in healthcare, the most pressing questions in cardiovascular medicine demand immediate answers. These challenges and more will be tackled head-on at the third annual TCT(r) MedTech Innovation Forum on Sunday, October 27, at the Walter E. Washington Convention Center in Washington, DC. This full-day event, organized by a partnership among the Cardiovascular Research Foundation(r) (CRF(r)), Fogarty Innovation, and the FDA, launches TCT(r) 2024. Visionary leaders from across the medtech landscape will convene to explore bold solutions, share pioneering insights, and shape the future of cardiovascular care. The complete program is now available online. Cardiovascular Research Foundation (CRF) /articles/crf-announces-tct-2024-late-breaking-clinical-trials-and-science/?sc=rsin /articles/crf-announces-tct-2024-late-breaking-clinical-trials-and-science/?sc=rsin Tue, 27 Aug 2024 16:05:16 EST The Cardiovascular Research Foundation (CRF) is pleased to announce the late-breaking clinical trials and science to be featured at TCT 2024. Cardiovascular Research Foundation (CRF) /articles/new-york-valves-2024-late-breaking-clinical-trials-and-science-announced/?sc=rsin /articles/new-york-valves-2024-late-breaking-clinical-trials-and-science-announced/?sc=rsin Wed, 22 May 2024 09:05:54 EST The Cardiovascular Research Foundation(r) (CRF(r)) has announced New York Valves: The Structural Heart Summit will feature 12 Late-Breaking Clinical Trials and Science presentations. New York Valves 2024, the expanded iteration of our renowned annual Transcatheter Valve Therapy (TVT(r)) conference, will take place June 5-7, 2024, at the Jacob K. Javits Convention Center, North in New York City. Cardiovascular Research Foundation (CRF) /articles/tct-2024-master-operator-award-to-be-presented-to-jeffrey-w-moses-md/?sc=rsin /articles/tct-2024-master-operator-award-to-be-presented-to-jeffrey-w-moses-md/?sc=rsin Mon, 06 May 2024 14:05:09 EST The TCT Geoffrey O. Hartzler Master Operator Award will be presented to Jeffrey W. Moses, MD, during Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT will take place October 27-30, 2024, in Washington, DC, at the Walter E. Washington Convention Center. Cardiovascular Research Foundation (CRF) /articles/tct-2024-career-achievement-award-to-be-presented-to-robert-a-harrington-md/?sc=rsin /articles/tct-2024-career-achievement-award-to-be-presented-to-robert-a-harrington-md/?sc=rsin Mon, 29 Apr 2024 12:05:24 EST The TCT 2024 Career Achievement Award will be presented to Robert A. Harrington, MD, during Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT will take place October 27-30 2024, in Washington, DC at the Walter E. Washington Convention Center. Cardiovascular Research Foundation (CRF) /articles/aats-and-crf-partner-on-new-york-valves-the-structural-heart-summit/?sc=rsin /articles/aats-and-crf-partner-on-new-york-valves-the-structural-heart-summit/?sc=rsin Fri, 19 Apr 2024 11:05:36 EST The American Association for Thoracic Surgery (AATS) and the Cardiovascular Research Foundation (CRF) announced today a strategic partnership for CRF's New York Valves 2024: The Structural Heart Summit, making AATS the exclusive cardiothoracic surgical society partner of this preeminent valve meeting. Cardiovascular Research Foundation (CRF) /articles/introducing-new-york-valves-the-structural-heart-summit/?sc=rsin /articles/introducing-new-york-valves-the-structural-heart-summit/?sc=rsin Thu, 04 Apr 2024 12:05:05 EST The Cardiovascular Research Foundation (CRF) is excited to introduce New York Valves: The Structural Heart Summit, the expanded next iteration of our renowned annual Transcatheter Valve Therapy (TVT) conference. Cardiovascular Research Foundation (CRF) /articles/media-registration-for-tct-2024-now-open/?sc=rsin /articles/media-registration-for-tct-2024-now-open/?sc=rsin Tue, 26 Mar 2024 14:05:54 EST Media registration is now open for TCT 2024 (Transcatheter Cardiovascular Therapeutics), the annual scientific symposium of the Cardiovascular Research Foundation (CRF). Cardiovascular Research Foundation (CRF) /articles/tht-2024-late-breaking-clinical-science-announced/?sc=rsin /articles/tht-2024-late-breaking-clinical-science-announced/?sc=rsin Thu, 29 Feb 2024 10:05:44 EST The complete list of late-breaking clinical science to be presented at THT 2024: Technology and Heart Failure Therapeutics is now available online. An international heart failure conference organized by the Cardiovascular Research Foundation(r) (CRF(r)), THT will take place March 4-6, 2024, at the Westin Boston Seaport in Boston, MA. Cardiovascular Research Foundation (CRF) /articles/crf-launches-scientific-excellence-top-10-set-10/?sc=rsin /articles/crf-launches-scientific-excellence-top-10-set-10/?sc=rsin Tue, 21 Nov 2023 11:05:29 EST The Cardiovascular Research Foundation (CRF), in conjunction with the Transcatheter Cardiovascular Therapeutics (TCT) 2023 conference, CRF's annual scientific symposium, announced today the launch of the CRF Scientific Excellence Top 10 (SET-10), a new global annual ranking recognizing academic contributions to interventional cardiovascular medicine. Cardiovascular Research Foundation (CRF) /articles/heartpoint-global-wins-tct-2023-shark-tank-innovation-competition/?sc=rsin /articles/heartpoint-global-wins-tct-2023-shark-tank-innovation-competition/?sc=rsin Thu, 26 Oct 2023 13:05:49 EST - The Cardiovascular Research Foundation (CRF) is pleased to announce that HeartPoint Global has won the TCT 2023 Shark Tank Innovation Competition for its novel multi-lumen stent system for interventional adjustment of pulmonary blood flow in congenital heart disease. The competition took place during Transcatheter Cardiovascular Therapeutics (TCT), the world's premier educational meeting specializing in interventional cardiovascular medicine, October 23-26 in San Francisco. The winner was also presented with the Jon DeHaan Foundation Award for Innovation in Cardiology. Cardiovascular Research Foundation (CRF) /articles/walgreens-and-the-cardiovascular-research-foundation-unite-to-improve-recognition-and-diagnosis-of-valvular-heart-disease-for-older-americans/?sc=rsin /articles/walgreens-and-the-cardiovascular-research-foundation-unite-to-improve-recognition-and-diagnosis-of-valvular-heart-disease-for-older-americans/?sc=rsin Wed, 18 Oct 2023 09:05:21 EST Walgreens and the Cardiovascular Research Foundation (CRF) today announced a collaboration to drive forward the PREVUE-VALVE study, a groundbreaking population-based clinical trial that aims to quantify the prevalence of valvular heart disease (VHD) among older Americans and pave the way for the development of new therapies and tools for VHD detection and diagnosis. Cardiovascular Research Foundation (CRF)